STD AIDS Market Analysis and Reports | USA Conference Series

Market Analysis - STD AIDS 2018

HIV infection and AIDS have become a major worldwide public health problem. According to WHO approximately 35 million people worldwide living with HIV/AIDS in 2013, unaware of the outcomes. AIDS (acquired immunodeficiency syndrome) is a chronic, potentially life-threatening condition caused by the human immunodeficiency virus (HIV) which damages the immune system and, interferes with body's ability to fight the organisms that cause disease. HIV is Sexually transmitted diseases which spread by contact with infected blood or from mother to child transmission during pregnancy, childbirth or breast-feeding. It can take years before HIV weakens the immune system to the point that the person is infected with AIDS.

With the generous response and support received from the participants of HIV/AIDS, STDs, & STIs International Conference. Conference Series proudly announces 6th International Conference on HIV/AIDS, STDs and STIs. (STD AIDS 2017) which is slated at October 29-30, 2018 San Francisco, USA. The theme of the conference is “Raising Global Awareness on STD/AIDS and Fighting the Stigma Surrounding the Disease”.

Conference Series Organizes 300 Conferences every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 400 Open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members. 

Infection rates are high in San Francisco and metro Cities. CA ranked 4th in the number of new AIDS cases, 7th in cumulative AIDS cases and 8th in the number of persons living with AIDS in 50 states, Miami show more than 26,000 people living with HIV/AIDS, and more than 9,500 of these (37%) have diagnosed AIDS cases. Approximately in World 123235 members are associated to HIV/AIDS, 56657 countries wise, 80 city wise. Global HIV/AIDS market, including branded products and generics, was valued at $11.3 billion in 2010.  $11.8 billion in 2011 and increase at a 4.6% compound annual growth rate (CAGR) over the 2011-2016 forecast periods to reach $14.1 billion in 2016. Branded products to treat HIV/AIDS were worth nearly $10.7 billion in 2010 and should reach $11 billion in 2011. This sector is expected to reach $13.2 billion in 2016.For more

 

From the beginning of the epidemic, almost 75 million people have been infected with the HIV virus and about 36 million people have died of HIV. Globally, 35.3 million [32.2–38.8 million] people were living with HIV at the end of 2012. An estimated 0.8% of adults aged 15–49 years worldwide are living with HIV, although the burden of the epidemic continues to vary considerably between countries and regions. Sub-Saharan Africa remains most severely affected, with nearly 1 in every 20 adults living with HIV and accounting for 71% of the people living with HIV worldwide.

Since the height of the epidemic in the mid-1980s, the annual number of new HIV infections in the United States has been reduced by more than two-thirds, from roughly 130,000 to 50,000 annually. Atlanta finds itself the number five ranked city when it comes to new diagnoses of HIV — a statistic that is rooted in HIV testing not being offered in places where most people get access to health care. Grady Hospital is the only emergency department in Atlanta that offers an HIV test to every patient regardless of why they are in need of care. Various universities and research institutes like EMORY university, CDC Atlanta etc performs various research based on HIV/AIDS.

 

 

Upcoming world-wide HIV AIDS Conferences

22nd International AIDS Conference | Amsterdam, the Netherlands | 23-27 July 2018

6th World Congress on Control and Prevention of HIV/AIDS, STDs & STIs August 27-29, 2018 Zurich, Switzerland

International AIDS Conference (AIDS 2018) will be held in Amsterdam, Netherlands (23-27 July 2018).

2nd International Conference & Expo on HIV & AIDS September 17-18, 2018 at Toronto, Canada.

2nd International Conference on Sexually Transmitted Diseases, Infections and AIDS October 17-18, 2018 Las Vegas, Neveda, USA

International Conference On HIV/AIDS, STDs & STIs Paris, France   June 18-20, 2018

The annual Conference on Retroviruses and Opportunistic Infections (CROI) HYNES CONVENTION CENTER Boston, Massachusetts  March 4–7, 2018

20th International Conference on HIV and AIDS London, United Kingdom May 14 - 15, 2018

27th Annual Canadian Conference on HIV/AIDS April 26th-29th, 2018

HIV Conference 2018 23-25 April, 2018 (Valencia, Spain)

22nd Annual HIV Update: Contemporary Issues in Management Course Thursday, May 31, 2018 (All day) to Saturday, June 2, 2018

HIV & Hepatitis in the Americas 2018 Thursday, April 19, 2018 (All day) to Sunday, April 22, 2018

HIV Medical Management: Clinical and Didactic Experience for Providers Monday, March 19, 2018 (All day) to Thursday, March 22, 2018

Society of Adolescent Health and Medicine (SAHM) Annual Meeting 2018

8th International Workshop of HIV & Women 2-3 March 2018, Boston

HIV Glasgow 2018 28-31 October 2018

Dear Attendees,

6th International Conference on HIV/AIDS, STDs and STIs is exclusively designed for immunologists & virologist, physicians, nurses/nurse-practitioners, pharmacists, psychologists, behavioral researchers, Health care professionals, social scientists, epidemiologists, social workers, AIDS service organization (ASO) staff, students, Researchers, Academicians, Practitioners, Early Career Scholars, students along with Industries and others engaged in endeavors related to STD AIDS research and business.

As HIV/AIDS is an alarming concern throughout the world, STD AIDS 2018 will mainly focus on issues like Primary HIV Infection, Transmission and Eradication Issues apart from this HIV Co-infection, HIV Current pharmaceutical design

As the premier event, we have developed a program with your interests in mind. We have not only increased the number of opportunities for you to network with colleagues from across the world but also introduced more focused sessions that will feature cutting edge presentations, special panel discussions, and livelier interaction with industry leaders and experts.

Join us in San Francisco, USA for the leading annual HIV/AIDS event and

Find the latest developments in HIV research and therapy
Lectures by the world's prominent professionals and poster presentations at every career stage
Network STD AIDS with colleagues from more than 50 countries
Awareness on novel tools and techniques to benefit your research

GROUP REGISTRATION

For group registration (10 participants and more) please contact the registration department at: hiv-stds@immunologyconferences.org


Contact 
Vinay Jetti
Program Manager
Email: vinayjetti@immunologyconferences.org 
Phone: +1- 702-508-5200 ext. 8030

Please register through by using the following link to avail early bird discounts
register at:  https://hiv-aids-std.conferenceseries.com/registration.php